Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers.
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 20
- Incorporated in 2018
- Headquartered in South San Francisco, California
- http://dayonebio.com
Opened at $25 after pricing 10 mln share IPO at at $16.00 per share, at the high of the $14-16 expected range
No comments:
Post a Comment